Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Ziv-aflibercept Efficacy in Better Regulating AMD
Phase 2
Completed
- Conditions
- Wet Age-related Macular DegenerationWet Macular Degeneration
- Interventions
- First Posted Date
- 2018-02-06
- Last Posted Date
- 2020-10-06
- Lead Sponsor
- Kapil Kapoor
- Target Recruit Count
- 62
- Registration Number
- NCT03423823
- Locations
- 🇺🇸
Wagner Macula & Retina Center, Virginia Beach, Virginia, United States
News
No news found